These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 16883016)
21. Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors. Higuchi M; Suzuki H; Gotoh M PET Clin; 2016 Jan; 11(1):47-55. PubMed ID: 26590443 [TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078 [TBL] [Abstract][Full Text] [Related]
23. The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation. Harada S; Sato S; Suzuki E; Okumura Y; Hiraki T; Gobara H; Mimura H; Kanazawa S; Kaji M; Fujiwara T Acta Med Okayama; 2011 Dec; 65(6):395-402. PubMed ID: 22189480 [TBL] [Abstract][Full Text] [Related]
24. A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET. Higuchi M; Honjo H; Shigihara T; Shishido F; Suzuki H; Gotoh M J Cancer Res Clin Oncol; 2014 Nov; 140(11):1957-63. PubMed ID: 24952227 [TBL] [Abstract][Full Text] [Related]
25. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness. Lee JM; Jin GY; Li CA; Chung GH; Lee SY; Han YM; Chung MJ; Kim CS Invest Radiol; 2003 Feb; 38(2):129-39. PubMed ID: 12544076 [TBL] [Abstract][Full Text] [Related]
27. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432 [TBL] [Abstract][Full Text] [Related]
28. Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Higaki F; Okumura Y; Sato S; Hiraki T; Gobara H; Mimura H; Akaki S; Tsuda T; Kanazawa S Ann Nucl Med; 2008 Apr; 22(3):157-63. PubMed ID: 18498029 [TBL] [Abstract][Full Text] [Related]
29. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography. Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of Ida Y; Tamai H; Shingaki N; Shimizu R; Maeshima S; Maekita T; Iguchi M; Terada M; Kitano M Cancer Imaging; 2020 Oct; 20(1):74. PubMed ID: 33076990 [TBL] [Abstract][Full Text] [Related]
31. Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning. Blokhuis TJ; van der Schaaf MC; van den Tol MP; Comans EF; Manoliu RA; van der Sijp JR Scand J Gastroenterol Suppl; 2004; (241):93-7. PubMed ID: 15696856 [TBL] [Abstract][Full Text] [Related]
32. Delineation gross tumor volume based on positron emission tomography images by a numerical approximation method. Chen Y; Chen X; Li F; Ji-An L Ann Nucl Med; 2014 Dec; 28(10):980-5. PubMed ID: 25096024 [TBL] [Abstract][Full Text] [Related]
33. Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer. Wang Y; Lanuti M; Bernheim A; Shepard JO; Sharma A Int J Hyperthermia; 2018; 35(1):1-8. PubMed ID: 29719997 [TBL] [Abstract][Full Text] [Related]
34. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701 [TBL] [Abstract][Full Text] [Related]
36. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET. Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085 [TBL] [Abstract][Full Text] [Related]
37. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. Koort JK; Mäkinen TJ; Knuuti J; Jalava J; Aro HT J Nucl Med; 2004 Aug; 45(8):1406-11. PubMed ID: 15299068 [TBL] [Abstract][Full Text] [Related]
38. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer]. Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393 [TBL] [Abstract][Full Text] [Related]
39. [Evaluating efficacy of transcatheter arterial chemo-embolization combined with radiofrequency ablation on patients with hepatocellular carcinoma by 18FDG-PET/CT]. Zhao M; Wu PH; Zeng YX; Zhang FJ; Huang JH; Fan WJ; Gu YK; Zhang L; Tan ZB; Lin YE Ai Zheng; 2005 Sep; 24(9):1118-23. PubMed ID: 16159437 [TBL] [Abstract][Full Text] [Related]
40. Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography. Xu H; Sun G; Wang H; Yue Q; Tang H; Wu Q Nucl Med Commun; 2013 Mar; 34(3):220-8. PubMed ID: 23276827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]